Literature DB >> 14557285

Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells.

Tomohiro Osanai1, Masayuki Saitoh, Satoko Sasaki, Hirofumi Tomita, Toshiro Matsunaga, Ken Okumura.   

Abstract

We demonstrated recently that plasma concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, are increased by high salt intake concomitantly with a decrease in plasma levels of NO in human hypertension. We investigated the effect of shear stress on ADMA release in 2 types of cells: transformed human umbilical vein endothelial cells (HUVECs; cell line ECV-304) and HUVECs. Exposure of ECV-304 cells and HUVECs to shear stress with the use of a cone-plate viscometer enhanced gene expression of protein arginine methyltransferase (PRMT-1), ADMA synthase. In HUVECs, the ratio of PRMT-1 to glyceraldehyde 3-phosphate dehydrogenase mRNA was increased by 2-fold by a shear stress of > or =15 dyne/cm2. A dominant-negative mutant of IkappaB kinase alpha and troglitazone at 8 micromol/L, an activator of peroxisome proliferator-activated receptor gamma, abolished the shear stress-induced increase in PRMT-1 gene expression in parallel with the blockade of nuclear factor (NF)-kappaB translocation into the nucleus. The activity of dimethylarginine dimethylaminohydrolase, the degradation enzyme of ADMA, was unchanged after shear stress < or =15 dyne/cm2 and was enhanced by 1.48+/-0.06-fold (P<0.05) by shear stress at 25 dyne/cm2. The release of ADMA was increased by 1.64+/-0.10-fold (P<0.05) by shear stress at 15 dyne/cm2 but was not affected by shear stress at 25 dyne/cm2. These results indicate that shear stress enhances gene expression of PRMT-1 and ADMA release via activation of the NF-kappaB pathway. Shear stress at higher magnitudes facilitates the degradation of ADMA, thus returning ADMA release levels to baseline.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557285     DOI: 10.1161/01.HYP.0000097805.05108.16

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

1.  Identification and characterization of a highly thermostable bacteriophage lysozyme.

Authors:  R Lavigne; Y Briers; K Hertveldt; J Robben; G Volckaert
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

2.  Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy.

Authors:  Tao He; Aili Guan; Yue Shi; Zhiming Ge; Hongyan Dai
Journal:  Herz       Date:  2015-04-22       Impact factor: 1.443

Review 3.  Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress.

Authors:  Balasubramaniyan Vairappan
Journal:  World J Hepatol       Date:  2015-03-27

4.  Force-induced changes in subnuclear movement and rheology.

Authors:  Elizabeth A Booth-Gauthier; Turi A Alcoser; Ge Yang; Kris N Dahl
Journal:  Biophys J       Date:  2012-12-18       Impact factor: 4.033

Review 5.  Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Authors:  Chris Baylis
Journal:  Nat Clin Pract Nephrol       Date:  2006-04

6.  Women are different: the role of coupling factor 6 in blood pressure regulation.

Authors:  Lisandra E de Castro Brás; Kristine Y DeLeon; Merry L Lindsey
Journal:  Hypertens Res       Date:  2012-02-02       Impact factor: 3.872

7.  The Role of Obesity in Preeclampsia.

Authors:  James M Roberts; Lisa M Bodnar; Thelma E Patrick; Robert W Powers
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

8.  Transient endothelial dysfunction following flow-mediated dilation assessment.

Authors:  Roberto Nerla; Antonio Di Monaco; Alfonso Sestito; Priscilla Lamendola; Enrico Di Stasio; Federica Romitelli; Gaetano Antonio Lanza; Filippo Crea
Journal:  Heart Vessels       Date:  2010-12-09       Impact factor: 2.037

Review 9.  Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.

Authors:  Seiji Ueda; Sho-Ichi Yamagishi; Yuriko Matsumoto; Kei Fukami; Seiya Okuda
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

10.  Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.

Authors:  Gregory J Kato; Zeneng Wang; Roberto F Machado; William C Blackwelder; James G Taylor; Stanley L Hazen
Journal:  Br J Haematol       Date:  2008-03-17       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.